The stock market sold off Friday on Trump tariffs and a bad jobs report. Here's what to do. Palantir, AMD headline another ...

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an ...

Moderna MRNA incurred a loss of $2.13 per share in the second quarter of 2025, narrower than the Zacks Consensus Estimate of ...

One of the most widely watched names in the healthcare sector is Hims & Hers Health Inc. (NYSE: HIMS), not only due to its ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Detailed price information for Mercadolibre Inc (MELI-Q) from The Globe and Mail including charting and trades.

Amazon.com AMZN delivered second-quarter 2025 earnings of $1.68 per share, which increased 36.6% from the year-ago quarter ...

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell. In the ...

According to Benzinga Pro, Hims & Hers Health's peer group average for short interest as a percentage of float is 8.31%, which means the company has more short interest than most of its peers. Did you ...

Hims & Hers Health ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the ...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions ...